PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer	Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm	Recruiting	Not stated	2026-08-20		NCT07775820

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
First Affiliated Hospital of Wenzhou Medical University	117
Nanfang Hospital, Southern Medical University	248
Second Affiliated Hospital of Nanchang University	90
Shenzhen People's Hospital	35
The First Affiliated Hospital of Guangzhou Medical University	95

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Nanfang Hospital, Southern Medical University	Guangzhou	China	2
Shenzhen People's Hospital	Shenzhen	China	26
The First Affiliated Hospital of Guangzhou Medical University	Guangzhou	China	3
The First Affiliated Hospital of Wenzhou Medical University	Wenzhou	China	1
The Second Affiliated Hospital of Nanchang University	Nanchang	China	3